Cell and Gene Therapy Catapult reveals significant growth in UK trials
News
Datapharm expands into US market through partnership with phactMI
Collaboration aims to enhance accessibility of medicines information
Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials
New partnership to advance precision medicine in lung cancer diagnosis
Actinogen boosts trial with Cambridge Cognition’s digital suite
Partnership aims to advance Alzheimer’s research with innovative tools
Owlstone Medical announces $27 million USD first close in Series E financing round
Funds to accelerate commercialisation and clinical trials of diagnostic tests
Oxford Drug Design achieves in vivo validation for novel cancer treatment
Promising results from mouse study lead to expanded trials
Pheno Therapeutics granted trial authorisation for MS candidate
First-in-human trial of PTD802 to commence following UK MHRA approval
Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease
Initiative aims to identify plasma-based biomarkers for early detection
AI set to revolutionise pharmaceutical R&D says GlobalData
Survey finds AI to enhance productivity and cut costs in the next 12 months
Gilead and LEO Pharma partner to develop oral STAT6 program
Companies aim to provide new treatments for inflammatory conditions
New therapy hope for prostate cancer patients
CR-discovered NXP800 shows promise in clinical trials
NICE recommends olaparib for BRCA-mutated breast cancer treatment
Groundbreaking approval provides new hope for patients in England and Wales
Cambridge Cognition highlights positive Cantab results
New FDA-approved schizophrenia treatment shows promise in clinical trials
Angelini Ventures co-leads Series A financing in Neumirna Therapeutics
Investment to support RNA therapeutics for epilepsy and neurological disorders
Novartis gene therapy set to enhance SMA treatment
OAV101 IT expands potential for type II SMA patients
